ReviewBMC nephrology2025

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update.

Matt Gittus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.